Identifying safety concerns from genetic data: lessons from the development of CCR5 inhibitors

Détails

Demande d'une copieDemande d'une copie
ID Serval
serval:BIB_665D580DA4A1
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Editorial
Collection
Publications
Institution
UNIL/CHUV
Titre
Identifying safety concerns from genetic data: lessons from the development of CCR5 inhibitors
Périodique
Antiviral Therapy
Auteur⸱e⸱s
Telenti  A., Egger  M.
ISSN
1359-6535 (Print)
Statut éditorial
Publié
Date de publication
2007
Volume
12
Numéro
2
Pages
147-8
Notes
Comment
Editorial
Mots-clé
Arthritis, Rheumatoid/drug therapy/genetics Cyclohexanes/*adverse effects *Drug Design Genotype HIV Fusion Inhibitors/*adverse effects HIV Infections/drug therapy/genetics Hepatitis C/chemically induced/genetics Humans Meta-Analysis Multiple Sclerosis/chemically induced/genetics Mutation Pharmacogenetics/*methods Receptors, CCR5/*antagonists & inhibitors/*genetics/metabolism Research Design Risk Assessment Risk Factors Triazoles/*adverse effects
OAI-PMH
oai:serval.unil.ch:BIB_665D580DA4A1
Pubmed
17503656
Web of science
000247111500001
Création de la notice
25/01/2008 15:45
Dernière modification de la notice
20/08/2019 15:22
Données d'usage